Fluticasone / salmeterol Alternatives Compared
Fluticasone / salmeterol | Trelegy Ellipta | Symbicort |
|
---|
Fluticasone / salmeterol | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | Symbicort (budesonide / formoterol) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for COPD - Maintenance, Asthma - Maintenance, Asthma, COPD, COPD - Acute. fluticasone / salmeterol may also be used for purposes not listed in this medication guide. |
Prescription only
Trelegy Ellipta is approved for the once-daily treatment of adults with chronic obstructive pulmonary disease (COPD) or for adults with asthma. Trelegy Ellipta is an option for the treatment of... View more |
Prescription only
Symbicort is a combination inhaler that contains budesonide (a corticosteroid) and formoterol (a long-acting bronchodilator). Symbicort should only be used in people with moderate-to-severe asthma... View more |
||||||||||||||||||||||||
More about Fluticasone / salmeterol | More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | More about Symbicort (budesonide / formoterol) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Fluticasone / salmeterol has an average rating of 4.8 out of 10 from a total of 268 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 51% reported a negative effect. |
Trelegy Ellipta has an average rating of 6.8 out of 10 from a total of 242 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 24% reported a negative effect. |
Symbicort has an average rating of 6.6 out of 10 from a total of 221 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: fluticasone / salmeterol side effects in more detail. |
See also: Trelegy Ellipta side effects in more detail. |
See also: Symbicort side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all fluticasone / salmeterol prices |
View all Trelegy Ellipta prices |
View all Symbicort prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Advair Diskus, Advair HFA, AirDuo Respiclick, Wixela Inhub |
N/A |
Other budesonide / formoterol brands include: Breyna | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
12.6 hours |
24 hours |
7.9 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 454 drugs are known to interact with fluticasone / salmeterol:
|
A total of 521 drugs are known to interact with Trelegy Ellipta:
|
A total of 796 drugs are known to interact with Symbicort:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
August 24, 2000 |
September 18, 2017 |
July 21, 2006 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.